| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $30.91M | $22.60M | $34.16M | $19.23M | $1.32M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $117.30M | $125.28M | $142.06M | $136.37M | $102.05M |
| R&D | $85.47M | $94.53M | $109.69M | $105.62M | $80.33M |
| SG&A | $27.55M | $28.36M | $32.37M | $30.75M | $21.73M |
| Operating Income | -$86.39M | -$102.68M | -$107.91M | -$117.14M | -$100.73M |
| Interest Expense | – | – | – | – | $1.91M |
| Tax Expense | $0.00 | $0.00 | $4.23M | $0.00 | – |
| Net Income | -$74.28M | -$86.62M | -$98.43M | -$108.88M | -$101.32M |
| EPS (basic) | -1.1800 | -1.5800 | -2.3400 | -2.6200 | -2.7300 |
| EPS (diluted) | -1.1800 | -1.5800 | -2.3400 | -2.6200 | -2.7300 |
| Shares (diluted) | $62.98M | $54.90M | $41.97M | $41.59M | $37.17M |